| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |